128 related articles for article (PubMed ID: 22086794)
1. The serum profile of adipokines in naïve patients with diabetes mellitus type 2 and obesity.
de Luis DA; Aller R; Izaola O; Ovalle HF
J Clin Lab Anal; 2011 Nov; 25(6):409-13. PubMed ID: 22086794
[TBL] [Abstract][Full Text] [Related]
2. Circulating adipocytokines in morbid obese patients, relation with cardiovascular risk factors and anthropometric parameters.
de Luis DA; González Sagrado M; Conde R; Aller R; Izaola O; Castro MJ
Nutr Hosp; 2011; 26(1):91-6. PubMed ID: 21519734
[TBL] [Abstract][Full Text] [Related]
3. Circulating adipocytokines in obese nondiabetic patients in relationship with cardiovascular risk factors, anthropometry and resting-energy expenditure.
de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O; Romero E
Ann Nutr Metab; 2007; 51(5):416-20. PubMed ID: 18025813
[TBL] [Abstract][Full Text] [Related]
4. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.
Hansen D; Dendale P; Beelen M; Jonkers RA; Mullens A; Corluy L; Meeusen R; van Loon LJ
Eur J Appl Physiol; 2010 Jun; 109(3):397-404. PubMed ID: 20131064
[TBL] [Abstract][Full Text] [Related]
5. Relation of the rs6923761 gene variant in glucagon-like peptide 1 receptor with weight, cardiovascular risk factor, and serum adipokine levels in obese female subjects.
de Luis DA; Aller R; de la Fuente B; Primo D; Conde R; Izaola O; Sagrado MG
J Clin Lab Anal; 2015 Mar; 29(2):100-5. PubMed ID: 24687535
[TBL] [Abstract][Full Text] [Related]
6. Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: A population-based study.
Liu W; Zhou X; Li Y; Zhang S; Cai X; Zhang R; Gong S; Han X; Ji L
Medicine (Baltimore); 2020 Feb; 99(6):e19052. PubMed ID: 32028423
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin, resistin and leptin response to dietary intervention in diabetic nephropathy.
Kozłowska L; Rydzewski A; Fiderkiewicz B; Wasińska-Krawczyk A; Grzechnik A; Rosołowska-Huszcz D
J Ren Nutr; 2010 Jul; 20(4):255-62. PubMed ID: 20537918
[TBL] [Abstract][Full Text] [Related]
8. Relation of C-reactive protein to obesity, adipose tissue hormones and cardiovascular risk factors in men treated with early percutaneous intervention in course of acute myocardial infarction.
Piestrzeniewicz K; Łuczak K; Komorowski J; Jankiewicz-Wika J; Goch JH
Neuro Endocrinol Lett; 2007 Aug; 28(4):427-32. PubMed ID: 17693973
[TBL] [Abstract][Full Text] [Related]
9. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
10. Dietary glycemic index/load and peripheral adipokines and inflammatory markers in elderly subjects at high cardiovascular risk.
Bulló M; Casas R; Portillo MP; Basora J; Estruch R; García-Arellano A; Lasa A; Juanola-Falgarona M; Arós F; Salas-Salvadó J
Nutr Metab Cardiovasc Dis; 2013 May; 23(5):443-50. PubMed ID: 22209741
[TBL] [Abstract][Full Text] [Related]
11. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.
Monzillo LU; Hamdy O; Horton ES; Ledbury S; Mullooly C; Jarema C; Porter S; Ovalle K; Moussa A; Mantzoros CS
Obes Res; 2003 Sep; 11(9):1048-54. PubMed ID: 12972674
[TBL] [Abstract][Full Text] [Related]
12. Association between four adipokines and insulin sensitivity in patients with obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population.
Yuan T; Zhao WG; Sun Q; Fu Y; Dong YY; Dong YX; Yang GH; Wang H
Chin Med J (Engl); 2010 Aug; 123(15):2018-22. PubMed ID: 20819535
[TBL] [Abstract][Full Text] [Related]
13. Local and serum levels of adipokines in patients with obesity after periodontal therapy: one-year follow-up.
Gonçalves TE; Zimmermann GS; Figueiredo LC; Souza Mde C; da Cruz DF; Bastos MF; da Silva HD; Duarte PM
J Clin Periodontol; 2015 May; 42(5):431-9. PubMed ID: 25858047
[TBL] [Abstract][Full Text] [Related]
14. Are adipokines associated with atrial fibrillation in type 2 diabetes?
Peller M; Kapłon-Cieślicka A; Rosiak M; Tymińska A; Ozierański K; Eyileten C; Kondracka A; Mirowska-Guzel D; Opolski G; Postuła M; Filipiak KJ
Endokrynol Pol; 2020; 71(1):34-41. PubMed ID: 33140400
[TBL] [Abstract][Full Text] [Related]
15. Adipokine Profile in Patients with Type 2 Diabetes Depends on Degree of Obesity.
Kocot J; Dziemidok P; Kiełczykowska M; Hordyjewska A; Szcześniak G; Musik I
Med Sci Monit; 2017 Oct; 23():4995-5004. PubMed ID: 29049270
[TBL] [Abstract][Full Text] [Related]
16. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis.
Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947
[TBL] [Abstract][Full Text] [Related]
17. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
[TBL] [Abstract][Full Text] [Related]
18. Classical (adiponectin, leptin, resistin) and new (chemerin, vaspin, omentin) adipocytokines in patients with prediabetes.
Gateva A; Assyov Y; Tsakova A; Kamenov Z
Horm Mol Biol Clin Investig; 2018 Jan; 34(1):. PubMed ID: 29332012
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes and metabolic syndrome - adipokine levels and effect of drugs.
Farooq R; Amin S; Hayat Bhat M; Malik R; Wani HA; Majid S
Gynecol Endocrinol; 2017 Jan; 33(1):75-78. PubMed ID: 27705028
[TBL] [Abstract][Full Text] [Related]
20. Association of Selected Adipocytokines and Inflammatory Markers on Body Mass Index in Type 2 Diabetes Patients in Saudi Arabia and as Risk Factors to Cardiovascular Disease.
Anandaraj AA; Syed Ismail PM; Namis SM; Bajnaid YJ; Shetty SB; Almutairi KM
Curr Diabetes Rev; 2017; 13(3):330-335. PubMed ID: 27296168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
